Educational information, reviewed by Ryan Arvizo, FNP-C. Current as of August 2026.
Semaglutide and tirzepatide are the two names most people mean when they say “GLP-1.” They’re related, they’re both well-studied, and they’re not the same. Here’s the plain-language difference.
The core difference: one pathway vs. two
- Semaglutide is a GLP-1 receptor agonist — it activates a single hormone pathway involved in appetite and blood-sugar regulation.
- Tirzepatide is a dual agonist — it activates two pathways (GLP-1 and GIP).
That extra pathway is the headline distinction, and it’s part of why the two can behave differently.
What the evidence shows
Both have a large, high-quality clinical-trial base — a genuinely stronger evidence footing than most therapies. In head-to-head and large trials, tirzepatide has generally produced a larger average weight loss, but “on average” is doing real work in that sentence: individual responses vary widely, and the best-tolerated option for you isn’t always the one with the bigger average.
Side effects and safety
Both are most commonly associated with gastrointestinal effects — nausea, reduced appetite, changes in digestion — usually managed by titrating the dose up slowly. Importantly, both carry an FDA Boxed Warning regarding thyroid C-cell tumors and are not appropriate for people with certain personal or family histories. This is exactly why they’re prescribed only after an evaluation, not chosen from a menu.
So which is right for you?
That’s not a question an article can answer, and anyone who tells you otherwise online is guessing. The choice depends on your history, how you tolerate the medication, your goals, insurance and access, and a provider’s clinical judgment. Both work best as part of ongoing, monitored care — alongside nutrition and activity — rather than a standalone quick fix.
The bottom line
Two strong, well-evidenced options with a real mechanistic difference and a shared safety profile. The comparison is a starting point for a conversation with a provider — not a self-diagnosis.
Sources
This information is educational and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Compounded medications are not FDA-approved. Treatments require evaluation by a licensed provider.